CN111008844A - Block chain-based drug tracing method, device and medium - Google Patents
Block chain-based drug tracing method, device and medium Download PDFInfo
- Publication number
- CN111008844A CN111008844A CN201911149896.9A CN201911149896A CN111008844A CN 111008844 A CN111008844 A CN 111008844A CN 201911149896 A CN201911149896 A CN 201911149896A CN 111008844 A CN111008844 A CN 111008844A
- Authority
- CN
- China
- Prior art keywords
- medicine
- tracing
- information
- drug
- block chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 249
- 238000000034 method Methods 0.000 title claims abstract description 55
- 229940079593 drug Drugs 0.000 title claims description 82
- 238000004519 manufacturing process Methods 0.000 claims abstract description 36
- 238000001514 detection method Methods 0.000 claims abstract description 34
- 230000008569 process Effects 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims description 15
- 238000003860 storage Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000007246 mechanism Effects 0.000 claims description 5
- 238000012377 drug delivery Methods 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 238000013523 data management Methods 0.000 claims 1
- 238000004804 winding Methods 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 2
- 238000010586 diagram Methods 0.000 description 9
- 238000004590 computer program Methods 0.000 description 7
- 239000003962 counterfeit drug Substances 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013475 authorization Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/018—Certifying business or products
- G06Q30/0185—Product, service or business identity fraud
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
- G06F16/27—Replication, distribution or synchronisation of data between databases or within a distributed database system; Distributed database system architectures therefor
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/60—Protecting data
- G06F21/62—Protecting access to data via a platform, e.g. using keys or access control rules
- G06F21/6218—Protecting access to data via a platform, e.g. using keys or access control rules to a system of files or objects, e.g. local or distributed file system or database
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/60—Protecting data
- G06F21/64—Protecting data integrity, e.g. using checksums, certificates or signatures
Landscapes
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Computer Security & Cryptography (AREA)
- General Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- Databases & Information Systems (AREA)
- Software Systems (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Computer Hardware Design (AREA)
- Bioethics (AREA)
- Entrepreneurship & Innovation (AREA)
- Data Mining & Analysis (AREA)
- Computing Systems (AREA)
- Accounting & Taxation (AREA)
- Development Economics (AREA)
- Economics (AREA)
- Finance (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- General Business, Economics & Management (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The application discloses a medicine tracing method, equipment and medium based on a block chain. The method for tracing the medicine source based on the block chain comprises the steps of auditing intelligent contracts to be subjected to chain winding, and sending the intelligent contracts to be subjected to chain winding which pass the auditing to each node to form intelligent contracts for tracing the medicine source; acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain; receiving an access instruction and acquiring medicine information on a medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises a medicine tracing code; and pushing the acquired medicine information to an access terminal. The medicine traceability block chain related in the medicine traceability method provided by the invention has the uniqueness that the medicine information and the detection certificate can be kept by the non-tampering performance, and can accurately and quickly provide data such as materials in different states in the medicine production, circulation and detection processes to consumers in real time, thereby realizing the traceability of the whole medicine production process.
Description
Technical Field
The application relates to the technical field of medical product information, in particular to a block chain-based drug traceability method, device and medium.
Background
In recent years, the problem of counterfeit drugs is always puzzling consumers, and many people suffer from the problems and have pain in disguising the counterfeit drugs. However, no effective method for preventing and controlling counterfeit drugs is available, so that consumers can be prevented from loss, various links of drug production, circulation and detection are effectively supervised, information can be traced in the whole process, and once counterfeit drugs are found, tracing can be quickly performed.
Consumers often worry about the authenticity, quality and circulation channel of the medicine when purchasing the commodity, especially the medicine. When the medicine is sold, the medicine production enterprises also need to master the goods spreading condition of the medicine, and effectively manage the medicine sale, on one hand, the medicine with problems can be recalled quickly, and on the other hand, the illegal persons are prevented from imitating the medicine produced and sold by the illegal persons.
At present, some medicine tracing methods and technologies exist, but the existing methods have the disadvantages that on one hand, in the existing tracing methods, medicine information data are all stored on a data platform with a centralized structure, the centralized data storage mode is easy to attack or damage, and the stability and the reliability cannot be guaranteed; in addition, centralized data storage cannot prevent data from being tampered and counterfeited, and authenticity and authority of the data cannot be guaranteed.
Therefore, there is an urgent need to develop a novel drug tracing method, which ensures that drug data cannot be falsified and is convenient to query, realizes full life cycle, full process and full element datamation of drug production, circulation and detection, realizes traceability and accountability of counterfeit and inferior drugs, and constructs a brand new trust mechanism of consumers for drug quality.
Disclosure of Invention
The embodiment of the specification provides a block chain-based drug tracing method, device and medium, which are used for solving the following technical problems in the prior art: consumers or other demand parties often have difficulty in really and objectively knowing information of links such as drug production, circulation, detection and the like, cannot effectively trace the source of drug information, and have difficulty in distinguishing fake and counterfeit drugs.
The embodiment of the specification adopts the following technical scheme:
a drug tracing method based on a blockchain comprises the following steps:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises a code for identifying the medicine tracing source;
and pushing the acquired medicine information to an access terminal.
Optionally, the method for tracing to the source of the drug based on the blockchain further includes:
setting a medicine source tracing block chain node, wherein the node at least comprises one of the following items: a drug raw material supplier, a process water supplier, a third-party detection mechanism and a supervision department.
Optionally, the method for tracing to the source of a drug based on a blockchain further includes:
setting a medicine tracing intelligent contract, wherein the setting of the medicine tracing intelligent contract at least comprises writing the medicine raw material supplier condition, the operating personnel sanitation condition, the third party institution detection certificate and the supervision department information into the medicine tracing intelligent contract.
Optionally, the drug information includes at least one of: drug production information, drug circulation information, drug detection information.
Optionally, the drug production information includes at least one of: medicine raw material information and medicine water consumption information.
Optionally, the drug circulation information includes at least one of: health information, production equipment information, and production environment information.
Optionally, the drug detection information includes at least one of: drug delivery detection certificates, third party detection agency certificates, and regulatory authority certificates.
Optionally, the drug traceability code comprises at least one of: two-dimensional code, bar code, RFID label.
A blockchain-based drug traceability device, comprising:
at least one processor; and the number of the first and second groups,
a memory communicatively coupled to the at least one processor; wherein,
the memory stores instructions executable by the at least one processor to enable the at least one processor to:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
and receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises the identification of the medicine tracing code.
A blockchain-based drug provenance non-volatile computer storage medium storing computer-executable instructions configured to:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
and receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises the identification of the medicine tracing code.
The embodiment of the specification adopts at least one technical scheme which can achieve the following beneficial effects: each node on the drug traceability block chain can check whether the intelligent contract to be subjected to chain loading meets the agreement or not, and the verified drug traceability intelligent contracts are uniformly sent to each node of the drug traceability block chain; associating and uploading the medicine information and the medicine tracing code to a medicine tracing source block chain; the consumer or other demander can scan the code and send out an instruction to obtain the required medicine information, such as medicine raw materials, production inspection conditions, detection certificates and the like. The data based on the drug traceability block chain has public transparency, and a consumer can clearly see real and untrustworthy data, so that the public trust of drug data is guaranteed, and the safety of the consumer on purchased drugs is doubled. Meanwhile, the integrity of the chain-linked medicine production and suppliers can be improved, and the brand influence is improved.
Drawings
The accompanying drawings, which are included to provide a further understanding of the application and are incorporated in and constitute a part of this application, illustrate embodiment(s) of the application and together with the description serve to explain the application and not to limit the application. In the drawings:
fig. 1 is a schematic flowchart of a block chain-based drug tracing method according to an embodiment of the present disclosure;
fig. 2 is a schematic diagram of an operating principle of a block chain-based drug tracing method according to an embodiment of the present disclosure.
Detailed Description
In order to make the objects, technical solutions and advantages of the present disclosure more apparent, the technical solutions of the present disclosure will be clearly and completely described below with reference to the specific embodiments of the present disclosure and the accompanying drawings. It should be apparent that the described embodiments are only some of the embodiments of the present application, and not all of the embodiments. All other embodiments obtained by a person skilled in the art without making any inventive step based on the embodiments in the description belong to the protection scope of the present application.
The technical solutions provided by the embodiments of the present application are described in detail below with reference to the accompanying drawings.
The scheme of the application provides a block chain-based drug tracing method and a corresponding scheme. Fig. 1 is a schematic flowchart of a block chain-based drug tracing method according to an embodiment of the present disclosure. The method for tracing the medicine source based on the block chain comprises the steps of auditing intelligent contracts to be subjected to chain winding, and sending the intelligent contracts to be subjected to chain winding which pass the auditing to each node to form intelligent contracts for tracing the medicine source; acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain; receiving an access instruction and acquiring medicine information on a medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises a medicine tracing code; and pushing the acquired medicine information to an access terminal.
The intelligent contract is a built-in contract formed by an algorithm code based on a rule agreed in advance, and the automation and the intelligence of the performance can be realized by arranging the intelligent contract on a block chain. According to the block chain-based medicine traceability method, intelligent contracts to be subjected to chain winding are public, each node on the medicine traceability block chain can check the intelligent contracts to be subjected to chain winding, and whether the intelligent contracts to be subjected to chain winding meet the agreement is checked; and uniformly sending the audited intelligent contracts to be linked to each node of the medicine tracing source block chain to form the medicine tracing intelligent contracts. Meanwhile, drug information is associated with the drug tracing code and uploaded to the drug tracing block chain. The consumer or other demander can inquire the information of the medicine, such as raw materials of the medicine, production inspection condition, detection certificate and the like, by a certain mode, such as code scanning.
Because the intelligent contract can only be changed in an upgrading mode, each node needs to be synchronously deployed, and once the intelligent contract is deployed, the intelligent contract can only be executed through a program without human factor interference, so that the stability and the credibility of the medicine information data are enhanced. Meanwhile, data on the drug traceability block chain are data which can not be tampered, and the public trust and traceability of drug information are guaranteed.
In some embodiments of the present application, the method for drug tracing based on a blockchain further includes setting a drug tracing blockchain node. The method is characterized in that a medicine raw material supplier, a process water supplier, a third-party detection mechanism, a supervision department and the like are used as different nodes on a medicine traceability block chain, a set of medicines are represented on the nodes from raw materials to production and then to detection links, data generated on each node can be synchronized to other nodes, and the data of the medicine production, circulation and detection links are superposed into a medicine traceability block along time according to transmission history and are pushed in one direction strictly according to time sequence. The data tampering of a single node can not actually take effect, so that the drug information uploaded by each node is authentic and credible, and can be traced through related ways, and the credibility and accuracy of the drug information are protected.
In some embodiments of the present application, the method for tracing a medicine source based on a blockchain further includes setting an intelligent contract for tracing a medicine source. For the consumer, the chemical content and authenticity of the pharmaceutical material are important, not only to be transparent and to ensure fairness, but also to ensure the accuracy of the data. And writing the conditions of the drug raw material suppliers, the sanitation conditions of operators, the detection certificates of third-party institutions and the information of supervision departments into the drug traceability intelligent contract. Consumers or other demand parties can trigger the drug traceability intelligent contract in a certain mode, drug information can be automatically inquired by triggering the drug traceability intelligent contract, and the drug information can be automatically pushed to the access terminal. Each node can push medicine information to the access terminal after being triggered, but the specific pushed information can be different, such as the content data of chemical substances in the raw materials for medicine production pushed by a raw material supplier; the third-party detection mechanism pushes a medicine detection report and a detection certificate; and the supervision department pushes supervision data.
The drug information that may be pushed to the access terminal may include, for example, at least one of: drug production information, drug circulation information, drug detection information.
As shown in fig. 2, the drug production information may be data directly used in the production process, or other data capable of indirectly guiding the production or the improvement of the subsequent production. The drug production information may include, for example, at least one of: medicine raw material information, medicine water consumption information, enterprise qualification and standard statement. In addition to the enterprise itself, other parties involved in the production of the product (e.g., raw material suppliers, foundry manufacturers, third-party integrators, etc.) may also provide production data of the pharmaceutical product under the authorization of the enterprise.
The drug circulation information includes, for example, at least one of: health information, production equipment information, production environment information, production process, product certification, production flow data and the like.
The drug detection information includes, for example, at least one of: drug delivery detection certificates, third party detection agency certificates, and regulatory authority certificates. For example, the system can also comprise government detection data, sampling inspection data of a supervision department, detection condition reports of a detection organization and the like. The supervision data may be specific to the target enterprise or its products, such as detecting hardware conditions of a production plant of the target enterprise, sampling quality of product samples, and the like.
In some embodiments of the present application, the consumer is a user of the product, often the party with the longest product time, and is the actual witness of the product quality, and the consumer can obtain the drug information from the drug traceability block chain by scanning a traceability code, for example, including at least one of: two-dimensional code, bar code, RFID label. The consumer or other demanders can scan the corresponding medicine tracing code through scanning equipment such as a smart phone, a palm computer, a desktop computer and the like.
Based on the scheme, the provided medicine tracing method based on the block chain enables information data of medicine production, circulation and detection to have public transparency, and a consumer can clearly see real and untrustworthy data, so that the public credibility of medicine information is guaranteed, and the safety sense of the consumer on purchased medicines is doubled. Meanwhile, the integrity of the chain-linked medicine production and suppliers can be improved, and the brand influence is improved.
Based on the same idea, some embodiments of the present application further provide a device and a non-volatile computer storage medium corresponding to the above-described platform.
Some embodiments of the present application provide a blockchain-based drug tracing apparatus corresponding to fig. 1, including:
at least one processor; and the number of the first and second groups,
a memory communicatively coupled to the at least one processor; wherein,
the memory stores instructions executable by the at least one processor to enable the at least one processor to:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
and receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises the identification of the medicine tracing code.
Some embodiments of the present application provide a non-volatile computer storage medium corresponding to a blockchain-based drug tracing of fig. 1, storing computer-executable instructions configured to:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
and receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises the identification of the medicine tracing code.
The embodiments in the present application are described in a progressive manner, and the same and similar parts among the embodiments can be referred to each other, and each embodiment focuses on the differences from the other embodiments. In particular, for the device and media embodiments, the description is relatively simple as it is substantially similar to the method embodiments, and reference may be made to some descriptions of the method embodiments for relevant points.
The device and the medium provided by the embodiment of the application correspond to the method one to one, so the device and the medium also have the similar beneficial technical effects as the corresponding method, and the beneficial technical effects of the method are explained in detail above, so the beneficial technical effects of the device and the medium are not repeated herein.
As will be appreciated by one skilled in the art, embodiments of the present invention may be provided as a method, system, or computer program product. Accordingly, the present invention may take the form of an entirely hardware embodiment, an entirely software embodiment or an embodiment combining software and hardware aspects. Furthermore, the present invention may take the form of a computer program product embodied on one or more computer-usable storage media (including, but not limited to, disk storage, CD-ROM, optical storage, and the like) having computer-usable program code embodied therein.
The present invention is described with reference to flowchart illustrations and/or block diagrams of methods, apparatus (systems), and computer program products according to embodiments of the invention. It will be understood that each flow and/or block of the flow diagrams and/or block diagrams, and combinations of flows and/or blocks in the flow diagrams and/or block diagrams, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, embedded processor, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions specified in the flowchart flow or flows and/or block diagram block or blocks.
These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the function specified in the flowchart flow or flows and/or block diagram block or blocks.
These computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart flow or flows and/or block diagram block or blocks.
In a typical configuration, a computing device includes one or more processors (CPUs), input/output interfaces, network interfaces, and memory.
The memory may include forms of volatile memory in a computer readable medium, Random Access Memory (RAM) and/or non-volatile memory, such as Read Only Memory (ROM) or flash memory (flash RAM). Memory is an example of a computer-readable medium.
Computer-readable media, including both non-transitory and non-transitory, removable and non-removable media, may implement information storage by any method or technology. The information may be computer readable instructions, data structures, modules of a program, or other data. Examples of computer storage media include, but are not limited to, phase change memory (PRAM), Static Random Access Memory (SRAM), Dynamic Random Access Memory (DRAM), other types of Random Access Memory (RAM), Read Only Memory (ROM), Electrically Erasable Programmable Read Only Memory (EEPROM), flash memory or other memory technology, compact disc read only memory (CD-ROM), Digital Versatile Discs (DVD) or other optical storage, magnetic cassettes, magnetic tape magnetic disk storage or other magnetic storage devices, or any other non-transmission medium that can be used to store information that can be accessed by a computing device. As defined herein, a computer readable medium does not include a transitory computer readable medium such as a modulated data signal and a carrier wave.
It should also be noted that the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising an … …" does not exclude the presence of other like elements in a process, method, article, or apparatus that comprises the element.
The above description is only an example of the present application and is not intended to limit the present application. Various modifications and changes may occur to those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the scope of the claims of the present application.
Claims (10)
1. A drug tracing method based on a block chain is characterized by comprising the following steps:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises a code for identifying the medicine tracing source;
and pushing the acquired medicine information to an access terminal.
2. The blockchain-based drug tracing method according to claim 1, further comprising:
setting a medicine source tracing block chain node, wherein the node at least comprises one of the following items: a drug raw material supplier, a process water supplier, a third-party detection mechanism and a supervision department.
3. The blockchain-based drug tracing method according to claim 1, further comprising:
setting a medicine tracing intelligent contract, wherein the setting of the medicine tracing intelligent contract at least comprises writing the medicine raw material supplier condition, the operating personnel sanitation condition, the third party institution detection certificate and the supervision department information into the medicine tracing intelligent contract.
4. The blockchain-based drug tracing method according to claim 1, wherein:
the drug information includes at least one of: drug production information, drug circulation information, drug detection information.
5. The blockchain-based drug tracing method according to claim 4, wherein:
the drug production information includes at least one of: medicine raw material information and medicine water consumption information.
6. The blockchain-based drug tracing method according to claim 4, wherein:
the drug circulation information includes at least one of: health information, production equipment information, and production environment information.
7. The blockchain-based drug tracing method according to claim 4, wherein:
the drug detection information includes at least one of: drug delivery detection certificates, third party detection agency certificates, and regulatory authority certificates.
8. The blockchain-based drug tracing method according to claim 1, wherein the blockchain-based drug tracing method is characterized in that
The medicine tracing code at least comprises one of the following items: two-dimensional code, bar code, RFID label.
9. The utility model provides a medicine equipment of tracing to source based on block chain which characterized in that includes:
at least one processor; and the number of the first and second groups,
a memory communicatively coupled to the at least one processor; wherein,
the memory stores instructions executable by the at least one processor to enable the at least one processor to:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
and receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises the identification of the medicine tracing code.
10. A non-transitory computer storage medium for full factor quality data management, storing computer-executable instructions, the computer-executable instructions configured to:
auditing the intelligent contracts to be chain-linked, and sending the audited intelligent contracts to be chain-linked to each node to form medicine source-tracing intelligent contracts;
acquiring medicine information, associating the medicine information with a medicine tracing code, and uploading the medicine information to a medicine tracing block chain;
and receiving an access instruction and acquiring the medicine information on the medicine tracing block chain according to the medicine tracing intelligent contract, wherein the access instruction comprises the identification of the medicine tracing code.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911149896.9A CN111008844A (en) | 2019-11-21 | 2019-11-21 | Block chain-based drug tracing method, device and medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911149896.9A CN111008844A (en) | 2019-11-21 | 2019-11-21 | Block chain-based drug tracing method, device and medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111008844A true CN111008844A (en) | 2020-04-14 |
Family
ID=70113251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911149896.9A Pending CN111008844A (en) | 2019-11-21 | 2019-11-21 | Block chain-based drug tracing method, device and medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111008844A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111600790A (en) * | 2020-07-20 | 2020-08-28 | 百度在线网络技术（北京）有限公司 | Block chain based message processing method, device, equipment and storage medium |
| CN111611619A (en) * | 2020-05-26 | 2020-09-01 | 牛津(海南)区块链研究院有限公司 | Traceability method, traceability device, traceability equipment and readable storage medium based on alliance chain |
| CN111652335A (en) * | 2020-05-07 | 2020-09-11 | 济南浪潮高新科技投资发展有限公司 | Quality chain tracing method, equipment and medium based on NFC |
| CN111681015A (en) * | 2020-06-10 | 2020-09-18 | 复旦大学 | Product tracing method, system and equipment based on alliance chain |
| CN111861348A (en) * | 2020-08-04 | 2020-10-30 | 北京物资学院 | Cold chain traceability system based on block chain |
| CN112232832A (en) * | 2020-09-09 | 2021-01-15 | 重庆市亚特蓝电器有限责任公司 | Water dispenser tracing method and water dispenser tracing platform based on block chain |
| CN112699180A (en) * | 2020-12-24 | 2021-04-23 | 广东工业大学 | Medicine recall system and method based on block chain |
| CN112905710A (en) * | 2021-04-09 | 2021-06-04 | 甘肃省交通科学研究院集团有限公司 | Traffic product selective inspection system based on block chain and operation method thereof |
| CN113159795A (en) * | 2021-02-09 | 2021-07-23 | 北京工业大学 | Food tracing method based on double-chain block chain |
| CN113743955A (en) * | 2021-08-06 | 2021-12-03 | 广西综合交通大数据研究院 | Food material traceability data security access control method based on intelligent contract |
| CN113762983A (en) * | 2021-08-11 | 2021-12-07 | 成都华药共享网络科技有限公司 | Block chain-based medical product chain tracing method |
| CN114493637A (en) * | 2022-01-29 | 2022-05-13 | 山东浪潮工业互联网产业股份有限公司 | Block chain-based traditional Chinese medicine tracing method, equipment and medium |
| CN114493632A (en) * | 2022-01-24 | 2022-05-13 | 山东浪潮工业互联网产业股份有限公司 | Authentication method and equipment for real-year wine |
| CN114936868A (en) * | 2022-05-23 | 2022-08-23 | 蚂蚁区块链科技(上海)有限公司 | Product package tracing method and device and computing equipment |
| CN115829595A (en) * | 2023-02-14 | 2023-03-21 | 江西服装学院 | Garment products supply chain system of traceing back based on block chain |
| CN116071092A (en) * | 2023-03-20 | 2023-05-05 | 浪潮云洲(山东)工业互联网有限公司 | Prefabricated vegetable tracing method, system and equipment based on blockchain |
| CN117132298A (en) * | 2023-09-04 | 2023-11-28 | 上海钒锝科技有限公司 | Drug traceable management system |
| CN117649247A (en) * | 2023-11-24 | 2024-03-05 | 好心情健康产业集团有限公司 | Drug tracing method and device |
-
2019
- 2019-11-21 CN CN201911149896.9A patent/CN111008844A/en active Pending
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111652335A (en) * | 2020-05-07 | 2020-09-11 | 济南浪潮高新科技投资发展有限公司 | Quality chain tracing method, equipment and medium based on NFC |
| CN111611619B (en) * | 2020-05-26 | 2024-02-02 | 牛津(海南)区块链研究院有限公司 | Alliance chain-based tracing method, device, equipment and readable storage medium |
| CN111611619A (en) * | 2020-05-26 | 2020-09-01 | 牛津(海南)区块链研究院有限公司 | Traceability method, traceability device, traceability equipment and readable storage medium based on alliance chain |
| CN111681015A (en) * | 2020-06-10 | 2020-09-18 | 复旦大学 | Product tracing method, system and equipment based on alliance chain |
| CN111600790B (en) * | 2020-07-20 | 2021-08-17 | 百度在线网络技术（北京）有限公司 | Block chain based message processing method, device, equipment and storage medium |
| CN111600790A (en) * | 2020-07-20 | 2020-08-28 | 百度在线网络技术（北京）有限公司 | Block chain based message processing method, device, equipment and storage medium |
| CN111861348A (en) * | 2020-08-04 | 2020-10-30 | 北京物资学院 | Cold chain traceability system based on block chain |
| CN112232832A (en) * | 2020-09-09 | 2021-01-15 | 重庆市亚特蓝电器有限责任公司 | Water dispenser tracing method and water dispenser tracing platform based on block chain |
| CN112699180A (en) * | 2020-12-24 | 2021-04-23 | 广东工业大学 | Medicine recall system and method based on block chain |
| CN113159795A (en) * | 2021-02-09 | 2021-07-23 | 北京工业大学 | Food tracing method based on double-chain block chain |
| CN112905710A (en) * | 2021-04-09 | 2021-06-04 | 甘肃省交通科学研究院集团有限公司 | Traffic product selective inspection system based on block chain and operation method thereof |
| CN113743955A (en) * | 2021-08-06 | 2021-12-03 | 广西综合交通大数据研究院 | Food material traceability data security access control method based on intelligent contract |
| CN113762983A (en) * | 2021-08-11 | 2021-12-07 | 成都华药共享网络科技有限公司 | Block chain-based medical product chain tracing method |
| CN114493632A (en) * | 2022-01-24 | 2022-05-13 | 山东浪潮工业互联网产业股份有限公司 | Authentication method and equipment for real-year wine |
| CN114493637A (en) * | 2022-01-29 | 2022-05-13 | 山东浪潮工业互联网产业股份有限公司 | Block chain-based traditional Chinese medicine tracing method, equipment and medium |
| CN114936868A (en) * | 2022-05-23 | 2022-08-23 | 蚂蚁区块链科技(上海)有限公司 | Product package tracing method and device and computing equipment |
| CN115829595A (en) * | 2023-02-14 | 2023-03-21 | 江西服装学院 | Garment products supply chain system of traceing back based on block chain |
| CN115829595B (en) * | 2023-02-14 | 2023-05-05 | 江西服装学院 | Clothing product supply chain traceability system based on block chain |
| CN116071092A (en) * | 2023-03-20 | 2023-05-05 | 浪潮云洲(山东)工业互联网有限公司 | Prefabricated vegetable tracing method, system and equipment based on blockchain |
| CN117132298A (en) * | 2023-09-04 | 2023-11-28 | 上海钒锝科技有限公司 | Drug traceable management system |
| CN117649247A (en) * | 2023-11-24 | 2024-03-05 | 好心情健康产业集团有限公司 | Drug tracing method and device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111008844A (en) | Block chain-based drug tracing method, device and medium | |
| RU2639015C1 (en) | Authenticity and quality control procedure of production in the process of manufacture and implementation | |
| CN110930167A (en) | Block chain-based medicine information recording method, equipment and medium | |
| CN112184268A (en) | Medicine traceability management method and system based on block chain technology | |
| CN109461008A (en) | Drug Administration method and system based on block chain | |
| Al-Bahri et al. | Smart system based on DOA & IoT for products monitoring & anti-counterfeiting | |
| Akhtar et al. | Traceability and detection of counterfeit medicines in pharmaceutical supply chain using blockchain-based architectures | |
| CN106600296B (en) | Anti-counterfeiting traceability method and system based on total amount control | |
| CN111415170A (en) | Block chain-based food tracing method and equipment and related storage medium | |
| CN111242651A (en) | Block chain-based vaccine manufacturing process supervision method | |
| CN110930168A (en) | Anti-counterfeiting method and device for anti-counterfeiting label based on block chain and storage medium | |
| US10193883B2 (en) | Systems and methods for product authentication | |
| CN111027900A (en) | Warehouse management method, device and medium based on block chain | |
| CN111008853A (en) | Block chain-based fast-selling product tracing method, equipment and medium | |
| CN112288441A (en) | Method, equipment and medium for tracing imported frozen meat based on block chain | |
| CN111292097A (en) | Supply chain tracing method, equipment and medium based on block chain | |
| CN110991840A (en) | Takeout platform, equipment and medium based on block chain | |
| CN110930169A (en) | Block chain-based meat production information management method, equipment and medium | |
| Lokesh et al. | Block Chain Based Supply Chain Management for Counterfeit Drugs in Pharmaceutical Industry | |
| Durá et al. | Blockchain for data originality in pharma manufacturing | |
| Butt et al. | Tractability, the mantra of block chain technology in the food supply chain | |
| CN117709981A (en) | Tobacco product monitoring method, device and management system | |
| CN111274608A (en) | Block chain-based enterprise authority management method, equipment and medium | |
| CN111091392A (en) | Furniture tracing method, equipment and medium based on block chain | |
| CN111125754A (en) | Tobacco source tracing method, equipment and medium based on block chain double-chain structure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20200814 Address after: Room 1-2301, Building 7, North District, Shandong Design and Creative Industry Park, No. 868 Tangye West Road, Licheng District, Jinan City, Shandong Province, 250102 Applicant after: SHANDONG INSPUR QUALINK TECHNOLOGY Co.,Ltd. Address before: Room 3110, S01 building, Langchao building, No. 1036, Langchao Road, high tech Zone, Jinan City, Shandong Province 250101 Applicant before: Shandong Aicheng Network Information Technology Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |